首页|期刊导航|生物化学与生物物理学报(英文版)|Exploring the antitumor effect of curcumin-piperlongumine hybrid molecule(CP)on EGFR-TKI-resistant non-small cell lung cancer using network pharmacological analysis and experimental verification
Exploring the antitumor effect of curcumin-piperlongumine hybrid molecule(CP)on EGFR-TKI-resistant non-small cell lung cancer using network pharmacological analysis and experimental verification
Shiyu Wang Jianchang Qian Qianwen Zhang Yinshuang Lai Huijing Huang Jing Yuan Shanxin Li Min Hui Peipei Wang Bingbing Chen Zhiguo Liu
生物化学与生物物理学报(英文版)2025,Vol.57Issue(11):1803-1813,11.
生物化学与生物物理学报(英文版)2025,Vol.57Issue(11):1803-1813,11.DOI:10.3724/abbs.2025076
Exploring the antitumor effect of curcumin-piperlongumine hybrid molecule(CP)on EGFR-TKI-resistant non-small cell lung cancer using network pharmacological analysis and experimental verification
Exploring the antitumor effect of curcumin-piperlongumine hybrid molecule(CP)on EGFR-TKI-resistant non-small cell lung cancer using network pharmacological analysis and experimental verification
摘要
关键词
non-small cell lung cancer/curcumin/piperlongumine/resistance/EGFR-TKI/PI3K/AKT pathwayKey words
non-small cell lung cancer/curcumin/piperlongumine/resistance/EGFR-TKI/PI3K/AKT pathway引用本文复制引用
Shiyu Wang,Jianchang Qian,Qianwen Zhang,Yinshuang Lai,Huijing Huang,Jing Yuan,Shanxin Li,Min Hui,Peipei Wang,Bingbing Chen,Zhiguo Liu..Exploring the antitumor effect of curcumin-piperlongumine hybrid molecule(CP)on EGFR-TKI-resistant non-small cell lung cancer using network pharmacological analysis and experimental verification[J].生物化学与生物物理学报(英文版),2025,57(11):1803-1813,11.基金项目
This work was supported by the grants from the National Natural Science Foundation of China(Nos.82203839 and 82273788)and the Natural Science Foundation of Zhejiang Province(No.LQ21H310007). (Nos.82203839 and 82273788)